Covid-19 Vaccine Price
- All
- News
- Videos
-
India Sent Medicine To 150 Countries During Covid Crisis: Health Minister
Union Health Minister Mansukh Mandaviya on Friday said that India sent medicines to 150 countries during covid crisis without increasing the price and compromising on the quality of the medicines.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
At UN, India's Covid Vaccine Swipe At West As It Defends Wheat Export Ban
Voicing concern over the hoarding of food grains and discrimination amid the "unjustified increase" in food prices, the government on Wednesday said that the issue should not go the way of Covid-19 vaccines.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
Centre Allows Private Centres To Charge Up To Rs 150 Above Vaccine Price
Centre has told the states that the precaution dose will be of the same COVID-19 vaccine as the one used for the administration of the first two doses. Private vaccine centres can charge Rs 150 per dose as service charge above the cost of vaccine.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre
Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Google Search, Maps, Assistant Will Now Provide COVID-19 Vaccine Availability, Doses, Cost Details in India
Google Search, Maps, and Assistant in India will now show additional information about vaccine availability and appointments. They will help people get information like availability of slots, expected pricing, information on doses, and more.
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
Oil Prices Drop, But On Track For Steep Weekly Gain
Even with coronavirus cases rising in the United States, all around Asia and parts of Europe, analysts said higher vaccination rates would limit the need for the harsh lockdowns that gutted demand during the peak of the pandemic last year.
-
Oil Edges Higher As Tight Supply Outweighs Virus Spread
Oil prices edged higher on Tuesday as investors bet that tight supply and rising vaccination rates will help to offset any impact on demand from surging COVID-19 cases worldwide.
-
Vaccinations Declined During Implementation Of Liberalized Strategy: Centre
During the implementation of "Liberalized Pricing and Accelerated National COVID-19 Vaccination Strategy" from May 1 to June 20, the total number of doses administered declined, the Lok Sabha was informed on Friday.
-
India Sent Medicine To 150 Countries During Covid Crisis: Health Minister
Union Health Minister Mansukh Mandaviya on Friday said that India sent medicines to 150 countries during covid crisis without increasing the price and compromising on the quality of the medicines.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
At UN, India's Covid Vaccine Swipe At West As It Defends Wheat Export Ban
Voicing concern over the hoarding of food grains and discrimination amid the "unjustified increase" in food prices, the government on Wednesday said that the issue should not go the way of Covid-19 vaccines.
-
Biological E's Corbevax Price Cut To Rs 250 Per Dose For Private Centres
Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.
-
Centre Allows Private Centres To Charge Up To Rs 150 Above Vaccine Price
Centre has told the states that the precaution dose will be of the same COVID-19 vaccine as the one used for the administration of the first two doses. Private vaccine centres can charge Rs 150 per dose as service charge above the cost of vaccine.
-
Coronavirus Highlights: Covishield, Covaxin Prices Cut To Rs 225
The prices of Covishield and Covaxin vaccines at private hospitals have been slashed by more than half. This comes a day before the Covid vaccine booster shots become available to all Indian adults.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Merck COVID-19 Pill Has Vital Indian Link, Maker Sees Stock Price Jump
India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co's experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.
-
Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre
Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Google Search, Maps, Assistant Will Now Provide COVID-19 Vaccine Availability, Doses, Cost Details in India
Google Search, Maps, and Assistant in India will now show additional information about vaccine availability and appointments. They will help people get information like availability of slots, expected pricing, information on doses, and more.
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
Oil Prices Drop, But On Track For Steep Weekly Gain
Even with coronavirus cases rising in the United States, all around Asia and parts of Europe, analysts said higher vaccination rates would limit the need for the harsh lockdowns that gutted demand during the peak of the pandemic last year.
-
Oil Edges Higher As Tight Supply Outweighs Virus Spread
Oil prices edged higher on Tuesday as investors bet that tight supply and rising vaccination rates will help to offset any impact on demand from surging COVID-19 cases worldwide.
-
Vaccinations Declined During Implementation Of Liberalized Strategy: Centre
During the implementation of "Liberalized Pricing and Accelerated National COVID-19 Vaccination Strategy" from May 1 to June 20, the total number of doses administered declined, the Lok Sabha was informed on Friday.
